Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Transorbital sonography in CIDP patients: No evidence for optic nerve hypertrophy.
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
The Outlook for Alemtuzumab in Multiple Sclerosis.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Predictors of recurrence following an initial episode of transverse myelitis.
Microglia - performers of the 21st century.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Long-term effects of intrathecal baclofen in multiple sclerosis.
Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
Lyme disease associated neuroretinitis - Case report.
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosis.
Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature.
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »